Researchers have found that a new vaccine for malaria may be more than 70% effective on children in a phase II clinical trial in Burkina Faso. No other vaccine comes close to that. The public health impacts could be far-reaching if the results continue in further trials, Halidou Tinto tells host Marco Werman. He is a professor of parasitology and principal investigator at the Clinical Research Unit of Nanoro, in Burkina Faso.
The article you just read is free because dedicated readers and listeners like you chose to support our nonprofit newsroom. Our team works tirelessly to ensure you hear the latest in international, human-centered reporting every weekday. But our work would not be possible without you. We need your help.
Make a gift today to help us reach our $25,000 goal and keep The World going strong. Every gift will get us one step closer.